LADENBURG THALMANN FINANCIAL SERVICES INC. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2019$704,000
+31.1%
32,667
+10.7%
0.00%0.0%
Q3 2019$537,000
-37.6%
29,501
+21.9%
0.00%
-33.3%
Q2 2019$861,000
+24.4%
24,195
+17.6%
0.01%
+20.0%
Q1 2019$692,000
+17.5%
20,580
+15.0%
0.01%0.0%
Q4 2018$589,000
-44.3%
17,895
+3.3%
0.01%
-44.4%
Q3 2018$1,057,000
-4.7%
17,323
+66.0%
0.01%
-10.0%
Q2 2018$1,109,0000.0%10,4380.0%0.01%0.0%
Q1 2018$1,109,000
+304.7%
10,438
+126.8%
0.01%
+233.3%
Q4 2017$274,000
+185.4%
4,603
+14.4%
0.00%
+200.0%
Q3 2017$96,000
+17.1%
4,025
-3.6%
0.00%0.0%
Q2 2017$82,000
-23.4%
4,175
-8.7%
0.00%0.0%
Q1 2017$107,000
-68.4%
4,575
-83.4%
0.00%
-80.0%
Q4 2016$339,000
+370.8%
27,536
+565.8%
0.01%
+400.0%
Q3 2016$72,000
+53.2%
4,136
+23.6%
0.00%0.0%
Q2 2016$47,000
+2.2%
3,345
+0.8%
0.00%0.0%
Q1 2016$46,000
-41.8%
3,318
-29.3%
0.00%0.0%
Q4 2015$79,000
+5.3%
4,693
-31.2%
0.00%
-50.0%
Q3 2015$75,000
-16.7%
6,818
-4.9%
0.00%0.0%
Q2 2015$90,000
+13.9%
7,1680.0%0.00%0.0%
Q1 2015$79,000
-11.2%
7,168
+24.3%
0.00%0.0%
Q4 2014$89,000
+30.9%
5,768
+3.0%
0.00%0.0%
Q3 2014$68,000
-5.6%
5,6000.0%0.00%0.0%
Q2 2014$72,000
+5.9%
5,6000.0%0.00%0.0%
Q1 2014$68,000
+33.3%
5,600
+24.4%
0.00%0.0%
Q4 2013$51,000
+34.2%
4,500
+25.0%
0.00%
+100.0%
Q3 2013$38,000
+660.0%
3,600
+800.0%
0.00%
Q2 2013$5,0004000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2016
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders